Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8485799 | Vaccine | 2018 | 7 Pages |
Abstract
This first formal assessment of VE in the UK zoster vaccination programme demonstrates good effectiveness of zoster vaccine, and very good protection against PHN. The findings provide evidence that VE is similar across the age groups targeted for vaccination in the UK, and on duration of protection of the vaccine in public health use. The study provides key information for decision-makers about the future direction of UK zoster vaccination programme, indicating that the live zoster vaccine may be more cost-effective than estimated previously. It also supports efforts to communicate the benefits of zoster vaccination to address the declining coverage observed across the UK.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jemma L. Walker, Nick J. Andrews, Gayatri Amirthalingam, Harriet Forbes, Sinead M. Langan, Sara L. Thomas,